查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451694

2024-2032 年男性不孕症市场报告（按测试类型、治疗、配销通路、最终用户和地区）

Male Infertility Market Report by Test Type, Treatment, Distribution Channel, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2023年全球男性不孕症市场规模达40亿美元。展望未来， IMARC Group预计到2032年市场规模将达到62亿美元，2024-2032年复合年增长率（CAGR）为4.79%。男性不孕症的盛行率不断上升、延迟生育的趋势不断上升、重大技术进步、生活方式的不断变化、对不孕症的认识不断提高以及辅助生殖技术的合法化是推动市场的一些主要因素。

男性不孕症是指男性因生殖系统原因而无法使女性伴侣受孕的情况。它通常归因于精子产生、品质或交付的问题。可能导致男性不孕的因素包括精子数量低、精子形状或活动力异常、荷尔蒙失衡、遗传因素以及某些医疗状况，如精索静脉曲张（阴囊静脉扩张）。过度饮酒、吸烟、吸毒和肥胖等生活方式因素也可能导致男性不孕。

全球男性不孕症发生率的上升是市场的重要驱动力。生活方式的改变、环境污染物和压力相关因素加剧了这种日益严重的担忧，因此需要诊断和治疗解决方案。此外，为了追求职业目标和其他生活愿望而延迟生育的趋势导致男性与年龄相关的生育问题增加。这刺激了对男性不孕症治疗和辅助生殖技术的需求。除此之外，由于教育活动和数位资源，人们对生育问题的认识不断提高，促使更多男性因不孕症而寻求医疗援助，从而推动了市场的成长。除此之外，久坐的生活方式、不良的饮食习惯以及接触环境毒素的增加也与精子品质和数量下降有关。随着人们越来越意识到这些因素，对抵消这些影响的干预和治疗的需求也随之增加。与此一致的是，医疗技术的进步提高了男性不孕症诊断程序和治疗方案的准确性。精子 DNA 碎片分析和先进的精子选择方法等创新技术提高了治疗效果。

男性不孕症市场趋势/驱动因素：

男性不孕症盛行率不断增加

久坐的生活方式、接触环境污染物和高压力等多种因素共同导致了男性生育问题的增加。这些因素会对精子的产生、品质和活力产生不利影响。随着男性不孕症的盛行率得到越来越多的认识，对准确诊断和有效治疗方案的需求不断增长。夫妇们正在寻求医疗专业知识来解决这些问题，从而导致咨询和生育服务的采用增加。

晚育趋势上升

由于社会规范和职业抱负的不断变化，推迟生育的趋势已愈演愈烈。然而，年龄增长与男性生育能力下降有关，包括精子品质下降和 DNA 碎片增加。这种现象为男性带来了与年龄相关的生育挑战。因此，男性不孕症市场见证了希望在晚年组建家庭的老年男性对保留生育能力和治疗选择的需求激增。这一趋势强调需要专门的干预措施来满足这一人群的独特需求。

重大技术进步

精子 DNA 碎片分析等创新技术可以更全面地评估精子品质。此外，先进的精子选择方法，例如磁激活细胞分选（MACS），可以提高成功受精的机会。这些技术提高了识别不孕症根本原因的准确性，并为医疗保健专业人员提供了更广泛的工具来客製化治疗计划。随着技术的不断发展，它有可能透过为患者提供更有效和个人化的解决方案来显着改善结果并促进男性不孕症市场的成长。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球男性不孕症市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按测试类型

  • 精子凝集
    • 市场走向
    • 市场预测
  • DNA断裂技术
    • 市场走向
    • 市场预测
  • 氧化压力分析
    • 市场走向
    • 市场预测
  • 电脑辅助精液分析
    • 市场走向
    • 市场预测
  • 精子穿透试验
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按处理方式

  • 药物
    • 市场走向
    • 市场预测
  • 辅助生殖技术和精索静脉曲张手术
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 医院药房
    • 市场走向
    • 市场预测
  • 药局和药局
    • 市场走向
    • 市场预测
  • 网路药局
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 医院和诊所
    • 市场走向
    • 市场预测
  • 生育中心
    • 市场走向
    • 市场预测
  • 研究机构
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Andrology Solutions
    • CinnaGen Co.
    • Halotech DNA
    • SCSA Diagnostics Inc.
    • Vitrolife
    • Zydus Lifesciences Limited
    • Intas Pharmaceuticals Ltd.
    • Endo International plc
Product Code: SR112024A6416

The global male infertility market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.79% during 2024-2032. The increasing prevalence of male infertility, rising trend of delayed parenthood, significant technological advancements, evolving lifestyles, increasing awareness about infertility, and legalization of assisted reproductive technologies are some of the major factors propelling the market.

Male infertility refers to the condition in which a man is unable to impregnate a female partner due to factors related to his reproductive system. It is often attributed to issues with sperm production, quality, or delivery. Factors that can contribute to male infertility include low sperm count, abnormal sperm shape or motility, hormonal imbalances, genetic factors, and certain medical conditions like varicocele (enlarged veins in the scrotum). Lifestyle factors such as excessive alcohol consumption, smoking, drug use, and obesity can also play a role in male infertility.

The rising incidence of male infertility worldwide is a significant driver for the market. Changing lifestyles, environmental pollutants, and stress-related factors contribute to this growing concern, necessitating the need for diagnostic and treatment solutions. Additionally, the trend of delaying parenthood to pursue career goals and other life aspirations has led to higher age-related fertility issues among men. This has spurred the demand for male infertility treatments and assisted reproductive technologies. Other than this, increasing awareness about fertility issues, thanks to educational campaigns and digital resources, has prompted more men to seek medical assistance for infertility problems, thus driving the market growth. Besides this, sedentary lifestyles, poor dietary habits, and increased exposure to environmental toxins have been linked to declining sperm quality and quantity. As individuals become more conscious of these factors, the demand for interventions and treatments to counteract these effects has risen. In line with this, advancements in medical technologies have improved the accuracy of diagnostic procedures and treatment options for male infertility. Innovative techniques such as sperm DNA fragmentation analysis and advanced sperm selection methods have enhanced treatment outcomes.

Male Infertility Market Trends/Drivers:

Increasing Prevalence of Male Infertility

A multitude of factors, including sedentary lifestyles, exposure to environmental pollutants, and high stress levels, have collectively contributed to a rise in fertility issues among men. These factors can adversely affect sperm production, quality, and motility. As the prevalence of male infertility becomes more recognized, there is a growing demand for accurate diagnostics and effective treatment options. Couples are seeking medical expertise to address these concerns, leading to increased consultations and adoption of fertility services.

Rising Trend of Delayed Parenthood

The trend of delaying parenthood has gained momentum due to evolving societal norms and career aspirations. However, advancing age is associated with a decline in male fertility, including decreased sperm quality and increased DNA fragmentation. This phenomenon has given rise to age-related fertility challenges among men. As a result, the male infertility market is witnessing a surge in demand for fertility preservation and treatment options among older men who wish to start families later in life. This trend emphasizes the need for specialized interventions that cater to the unique requirements of this demographic.

Significant Technological Advancements

Innovative techniques such as sperm DNA fragmentation analysis enable a more comprehensive assessment of sperm quality. Additionally, advanced sperm selection methods, such as magnetic-activated cell sorting (MACS), enhance the chances of successful fertilization. These technologies offer improved accuracy in identifying underlying causes of infertility and provide healthcare professionals with a wider range of tools to tailor treatment plans. As technology continues to evolve, it has the potential to significantly improve outcomes and contribute to the growth of the male infertility market by providing patients with more effective and personalized solutions.

Male Infertility Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global male infertility market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on test type, treatment, distribution channel and end user.

Breakup by Test Type:

Sperm Agglutination

DNA Fragmentation Technique

Oxidative Stress Analysis

Computer Assisted Semen Analysis

Sperm Penetration Assay

Others

DNA fragmentation technique dominates the market

The report has provided a detailed breakup and analysis of the market based on the test type. This includes sperm agglutination, DNA fragmentation technique, oxidative stress analysis, computer assisted semen analysis, sperm penetration assay, and others. According to the report, DNA fragmentation technique represented the largest segment.

The DNA fragmentation technique stands as the largest segment in the market breakup by test type due to its ability to offer deeper insights into male infertility. This technique assesses DNA damage within sperm, providing crucial information about sperm quality. As a result, it has gained prominence in accurately diagnosing the underlying causes of male infertility, guiding tailored treatment approaches for better outcomes.

Breakup by Treatment:

Medication

Assisted Reproductive Technology and Varicocele Surgery

Assisted reproductive technology and varicocele surgery hold the largest market share

A detailed breakup and analysis of the market based on the treatment has also been provided in the report. This includes medication and assisted reproductive technology and varicocele surgery. According to the report, assisted reproductive technology and varicocele surgery accounted for the largest market share.

ART, encompassing techniques like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), offers couples the opportunity to overcome various fertility challenges, including male factor infertility. The success rates and advancements in ART have positioned it as a leading choice. Varicocele surgery, on the other hand, is a well-established surgical intervention to treat varicoceles, which are dilated veins in the scrotum that can impede sperm production and quality. By surgically correcting varicoceles, blood flow is improved, potentially enhancing sperm production and motility. This procedure has demonstrated positive outcomes in restoring fertility potential. The popularity of these treatments arises from their proven efficacy, leading to their prominent status in the market's treatment landscape.

Breakup by Distribution Channel:

Hospitals Pharmacies

Pharmacies and Drug Stores

Online Pharmacies

Male infertility products are majorly distributed through hospital pharmacies

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospitals pharmacies, pharmacies and drug stores, and online pharmacies. According to the report, hospitals pharmacies represented the largest segment.

Hospitals offer a range of specialized diagnostic facilities, medical expertise, and treatment options under one roof. This makes them a primary destination for patients seeking comprehensive evaluation, consultations with fertility specialists, and advanced interventions, including assisted reproductive technologies (ART) and surgical procedures. Pharmacies play a crucial role by providing access to prescription medications, supplements, and fertility-related products that support male reproductive health. They serve as convenient points of access for patients to obtain prescribed medications for fertility treatment and management. Additionally, pharmacies offer a discreet environment where individuals can access over-the-counter fertility supplements and products that complement treatment plans.

Breakup by End User:

Hospitals and Clinics

Fertility Centers

Research Institutes

Others

Fertility centers account for the majority of the share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals and clinics, fertility centers, research institutes, and others. According to the report, fertility centers accounted for the largest market share.

These centers are dedicated to providing a wide range of services specifically tailored to individuals and couples facing fertility challenges. Fertility centers house a team of experienced reproductive endocrinologists, urologists, embryologists, and other specialists who collectively offer advanced diagnostic evaluations, personalized treatment plans, and assisted reproductive technologies (ART) under one roof. The multidisciplinary nature of fertility centers allows for a holistic approach to male infertility, encompassing medical assessments, laboratory analyses, and innovative treatments. These centers offer a supportive environment that addresses the emotional and physical aspects of fertility struggles. The availability of state-of-the-art technologies, cutting-edge procedures, and a comprehensive understanding of male reproductive health positions fertility centers as the preferred choice for individuals seeking expert guidance and successful outcomes in their journey towards overcoming male infertility.

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Europe exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe accounted for the largest market share.

The region possesses a well-developed healthcare infrastructure, including advanced medical facilities, fertility clinics, and research institutions, enabling efficient diagnosis and treatment of male infertility. Moreover, changing socio-cultural dynamics have led to increased awareness and acceptance of fertility issues, prompting more individuals and couples to seek medical intervention. European countries also prioritize reproductive health and offer comprehensive healthcare coverage, making fertility treatments more accessible to a larger population. The aging population across the region contributes to a growing demand for assisted reproductive technologies (ART) as delayed parenthood becomes more common. Furthermore, the strong presence of Europe in medical research and development fuels innovations in male infertility treatments, attracting both domestic and international patients seeking cutting-edge solutions.

Competitive Landscape:

Leading companies are investing significantly in research and development to create new and improved diagnostic tools, treatments, and technologies for male infertility. This includes developing innovative sperm analysis techniques, medications, and assisted reproductive technologies to enhance treatment outcomes. Additionally, key players often collaborate with academic institutions, research organizations, and healthcare providers to exchange knowledge, share insights, and drive advancements in male infertility diagnostics and treatments. These collaborations foster a synergistic approach to tackling complex challenges and developing comprehensive solutions. Other than this, recognizing the importance of raising awareness about male infertility, industry leaders are actively involved in educational initiatives. They offer information through online platforms, seminars, and healthcare professional training, aimed at increasing understanding of the condition and encouraging timely interventions. Moreover, key players engage in strategic expansion efforts to tap into emerging markets with growing demand for male infertility treatments. By extending their reach, they aim to provide access to advanced diagnostics and therapies to a wider patient population.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Andrology Solutions

CinnaGen Co.

Halotech DNA

SCSA Diagnostics Inc.

Vitrolife

Zydus Lifesciences Limited

Intas Pharmaceuticals Ltd.

Endo International plc.

Recent Developments:

Andrology Solutions has made recent advancements in the field of male infertility, including improvements in the understanding and management of male factor infertility. It has also worked on developing panels for male infertility genes, which have achieved high accuracy in diagnosing copy number variants (CNVs). These advancements contribute to the diagnosis and treatment of male infertility, allowing for more effective interventions and improved outcomes.

Halotech DNA, a leading international biotech company based in Madrid, has introduced innovative DNA fragmentation analysis systems for evaluating sperm quality. These systems are designed to assess the level of DNA damage in sperm cells, which can be a contributing factor to male infertility. This analysis helps in identifying the underlying causes of infertility and guides the selection of appropriate treatment options.

In 2022, SCSA Diagnostics Inc. developed a test called the SCSA (Sperm Chromatin Structure Assay), which is used to evaluate sperm chromatin structure and DNA strand breaks. The SCSA test is a two-fold simultaneous flow cytometry measure of the extent of sperm nuclear single (ss) and double (ds) strand DNA breaks. This test provides unique information about male infertility by assessing the integrity of sperm DNA, which is crucial for successful fertilization and embryo development.

Key Questions Answered in This Report

  • 1. What was the size of the global male infertility market in 2023?
  • 2. What is the expected growth rate of the global male infertility market during 2024-2032?
  • 3. What are the key factors driving the global male infertility market?
  • 4. What has been the impact of COVID-19 on the global male infertility market?
  • 5. What is the breakup of the global male infertility market based on the test type?
  • 6. What is the breakup of the global male infertility market based on the treatment?
  • 7. What is the breakup of the global male infertility market based on the distribution channel?
  • 8. What is the breakup of the global male infertility market based on the end user?
  • 9. What are the key regions in the global male infertility market?
  • 10. Who are the key players/companies in the global male infertility market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Male Infertility Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Sperm Agglutination
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 DNA Fragmentation Technique
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Oxidative Stress Analysis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Computer Assisted Semen Analysis
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Sperm Penetration Assay
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Treatment

  • 7.1 Medication
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Assisted Reproductive Technology and Varicocele Surgery
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospitals Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmacies and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Fertility Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Andrology Solutions
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 CinnaGen Co.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Halotech DNA
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 SCSA Diagnostics Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Vitrolife
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Zydus Lifesciences Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Intas Pharmaceuticals Ltd.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Endo International plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Male Infertility Market: Major Drivers and Challenges
  • Figure 2: Global: Male Infertility Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Male Infertility Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Male Infertility Market: Breakup by Test Type (in %), 2023
  • Figure 5: Global: Male Infertility Market: Breakup by Treatment (in %), 2023
  • Figure 6: Global: Male Infertility Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Male Infertility Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Male Infertility Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Male Infertility (Sperm Agglutination) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Male Infertility (Sperm Agglutination) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Male Infertility (DNA Fragmentation Technique) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Male Infertility (DNA Fragmentation Technique) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Male Infertility (Oxidative Stress Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Male Infertility (Oxidative Stress Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Male Infertility (Computer Assisted Semen Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Male Infertility (Computer Assisted Semen Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Male Infertility (Sperm Penetration Assay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Male Infertility (Sperm Penetration Assay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Male Infertility (Other Test Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Male Infertility (Other Test Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Male Infertility (Medication) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Male Infertility (Medication) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Male Infertility (Assisted Reproductive Technology and Varicocele Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Male Infertility (Assisted Reproductive Technology and Varicocele Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Male Infertility (Hospitals Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Male Infertility (Hospitals Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Male Infertility (Pharmacies and Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Male Infertility (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Male Infertility (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Male Infertility (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Male Infertility (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Male Infertility (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Male Infertility (Fertility Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Male Infertility (Fertility Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Male Infertility (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Male Infertility (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Male Infertility (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Male Infertility (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: United States: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: United States: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Canada: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Canada: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia-Pacific: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia-Pacific: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: China: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: China: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Japan: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Japan: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: India: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: India: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: South Korea: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: South Korea: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Australia: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Australia: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Indonesia: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Indonesia: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Europe: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Europe: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Germany: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Germany: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: France: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: France: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: United Kingdom: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: United Kingdom: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Italy: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Italy: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Spain: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Spain: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Russia: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Russia: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Latin America: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Latin America: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Brazil: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Brazil: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Mexico: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Mexico: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Middle East and Africa: Male Infertility Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Middle East and Africa: Male Infertility Market: Breakup by Country (in %), 2023
  • Figure 87: Middle East and Africa: Male Infertility Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: Male Infertility Industry: SWOT Analysis
  • Figure 89: Global: Male Infertility Industry: Value Chain Analysis
  • Figure 90: Global: Male Infertility Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Male Infertility Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Male Infertility Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 3: Global: Male Infertility Market Forecast: Breakup by Treatment (in Million US$), 2024-2032
  • Table 4: Global: Male Infertility Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Male Infertility Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Male Infertility Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Male Infertility Market: Competitive Structure
  • Table 8: Global: Male Infertility Market: Key Players